Cargando…

Impact of the Warhead of Dipeptidyl Keto Michael Acceptors on the Inhibition Mechanism of Cysteine Protease Cathepsin L

[Image: see text] Cathepsin L (CatL) is a lysosomal cysteine protease whose activity has been related to several human pathologies. However, although preclinical trials using CatL inhibitors were promising, clinical trials have been unsuccessful up to now. We are presenting a study of two designed d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernández-de-la-Pradilla, Adrián, Royo, Santiago, Schirmeister, Tanja, Barthels, Fabian, Świderek, Katarzyna, González, Florenci V., Moliner, Vicent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594577/ https://www.ncbi.nlm.nih.gov/pubmed/37881790 http://dx.doi.org/10.1021/acscatal.3c02748

Ejemplares similares

Impact of the Recognition Part of Dipeptidyl Nitroalkene Compounds on the Inhibition Mechanism of Cysteine Proteases Cruzain and Cathepsin L
por: Arafet, Kemel, et al.
Publicado: (2023)

Mechanism of inhibition of SARS-CoV-2 M(pro) by N3 peptidyl Michael acceptor explained by QM/MM simulations and design of new derivatives with tunable chemical reactivity
por: Arafet, Kemel, et al.
Publicado: (2020)

2-Sulfonylpyrimidines as Privileged Warheads for the Development of S. aureus Sortase A Inhibitors
por: Barthels, Fabian, et al.
Publicado: (2022)

Investigation of the Compatibility between Warheads and Peptidomimetic Sequences of Protease Inhibitors—A Comprehensive Reactivity and Selectivity Study
por: Müller, Patrick, et al.
Publicado: (2023)

New Cysteine Protease Inhibitors: Electrophilic (Het)arenes and Unexpected Prodrug Identification for the Trypanosoma Protease Rhodesain
por: Klein, Philipp, et al.
Publicado: (2020)

Development of Reduced Peptide Bond Pseudopeptide Michael Acceptors for the Treatment of Human African Trypanosomiasis
por: Previti, Santo, et al.
Publicado: (2022)

Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain
por: Previti, Santo, et al.
Publicado: (2022)

Design of Reversible, Cysteine-Targeted Michael Acceptors Guided by Kinetic and Computational Analysis
por: Krishnan, Shyam, et al.
Publicado: (2014)

Cysteine Protease Cathepsins in Atherosclerotic Cardiovascular Diseases
por: Wu, Hongxian, et al.
Publicado: (2018)

Naphthoquinones as Covalent Reversible Inhibitors of Cysteine Proteases—Studies on Inhibition Mechanism and Kinetics
por: Klein, Philipp, et al.
Publicado: (2020)

Correction to “Design of Reversible, Cysteine-Targeted Michael Acceptors Guided by Kinetic and Computational Analysis”
por: Krishnan, Shyam, et al.
Publicado: (2014)

Computational Study of the Addition of Methanethiol to 40+ Michael Acceptors as a Model for the Bioconjugation of Cysteines
por: Costa, Anna M., et al.
Publicado: (2021)

Reaction Mechanism of Organocatalytic Michael Addition of Nitromethane to Cinnamaldehyde: A Case Study on Catalyst Regeneration and Solvent Effects
por: Świderek, Katarzyna, et al.
Publicado: (2017)

Covalent Reversible Inhibitors of Cysteine Proteases Containing the Nitrile Warhead: Recent Advancement in the Field of Viral and Parasitic Diseases
por: Brogi, Simone, et al.
Publicado: (2022)

Exploring the Versatility of the Covalent Thiol–Alkyne Reaction with Substituted Propargyl Warheads: A Deciding Role for the Cysteine Protease
por: Mons, Elma, et al.
Publicado: (2021)

Rhenium(V) Complexes as Cysteine-Targeting Coordinate Covalent Warheads
por: Karges, Johannes, et al.
Publicado: (2023)

Covalent Warheads Targeting Cysteine Residue: The Promising Approach in Drug Development
por: Huang, Fangjiao, et al.
Publicado: (2022)

Selective Glucocorticoid Receptor Properties of GSK866 Analogs with Cysteine Reactive Warheads
por: Chirumamilla, Chandra S., et al.
Publicado: (2017)

Cathepsin F Cysteine Protease of the Human Liver Fluke, Opisthorchis viverrini
por: Pinlaor, Porntip, et al.
Publicado: (2009)

Cysteine protease cathepsin B mediates radiation-induced bystander effects
por: Peng, Yu, et al.
Publicado: (2017)

Cathepsin F of Teladorsagia circumcincta is a recently evolved cysteine protease
por: Sloan, Sarah, et al.
Publicado: (2020)

Cu-catalyzed carboboration of acetylene with Michael acceptors
por: Cheng, Tairan, et al.
Publicado: (2022)

A Warhead Substitution Study on the Coronavirus Main Protease Inhibitor Nirmatrelvir
por: Vankadara, Subramanyam, et al.
Publicado: (2022)

Revealing the molecular mechanisms of proteolysis of SARS-CoV-2 M(pro) by QM/MM computational methods
por: Świderek, Katarzyna, et al.
Publicado: (2020)

Cysteine Cathepsins in Tumor-Associated Immune Cells
por: Jakoš, Tanja, et al.
Publicado: (2019)

Proteolytic activation of the epithelial sodium channel (ENaC) by the cysteine protease cathepsin-S
por: Haerteis, Silke, et al.
Publicado: (2012)

Odanacatib, a Cathepsin K Cysteine Protease Inhibitor, Kills Hookworm In Vivo
por: Vermeire, Jon J., et al.
Publicado: (2016)

Upregulation of Cysteine Protease Cathepsin X in the 6-Hydroxydopamine Model of Parkinson’s Disease
por: Pišlar, Anja, et al.
Publicado: (2018)

Rational design of thioamide peptides as selective inhibitors of cysteine protease cathepsin L
por: Phan, Hoang Anh T., et al.
Publicado: (2021)

Apoferritin encapsulation of cysteine protease inhibitors for cathepsin L inhibition in cancer cells
por: Quilles Junior, José C., et al.
Publicado: (2019)

Nucleophilicity of Glutathione: A Link to Michael Acceptor Reactivities
por: Mayer, Robert J., et al.
Publicado: (2019)

Trifluoromethylcinnamanilide Michael Acceptors for Treatment of Resistant Bacterial Infections
por: Strharsky, Tomas, et al.
Publicado: (2022)

Michael acceptor molecules in natural products and their mechanism of action
por: Liang, Song-Ting, et al.
Publicado: (2022)

BANΔIT: B’‐Factor Analysis for Drug Design and Structural Biology
por: Barthels, Fabian, et al.
Publicado: (2020)

Natural Products as Cathepsin Inhibitors
por: Vidal-Albalat, Andreu, et al.
Publicado: (2016)

Phosphinate esters as novel warheads for activity-based probes targeting serine proteases
por: Kahler, Jan Pascal, et al.
Publicado: (2021)

Fragment-Sized and Bidentate (Immuno)Proteasome Inhibitors Derived from Cysteine and Threonine Targeting Warheads
por: Kollár, Levente, et al.
Publicado: (2021)

Cysteine Cathepsin Protease Inhibition: An update on its Diagnostic, Prognostic and Therapeutic Potential in Cancer
por: Soond, Surinder M., et al.
Publicado: (2019)

Distinct Dibasic Cleavage Specificities of Neuropeptide-Producing Cathepsin L and Cathepsin V Cysteine Proteases Compared to PC1/3 and PC2 Serine Proteases
por: Yoon, Michael C., et al.
Publicado: (2022)

Mapping the S1 and S1’ subsites of cysteine proteases with new dipeptidyl nitrile inhibitors as trypanocidal agents
por: Cianni, Lorenzo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cbgvgfmuekcls4t9e8u30iumch